United Therapeutics (UTHR) Return on Capital Employed Growth (3y) (2013 - 2026)
United Therapeutics (UTHR) Return on Capital Employed Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.86 Bn | 32.12 Bn | 1.97 Bn | 1,301.00 |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | 331.00 |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -667.00 |
| 5 | United Therapeutics | 23.15 Bn | 20.99 Bn | 648.10 Mn | 480.00 |
| 6 | RedHill Biopharma | 21.17 Bn | 21.17 Bn | - | - |
| 7 | Viatris | 20.32 Bn | 18.51 Bn | 1.16 Bn | -254.00 |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | 1,342.00 |
| 9 | Elanco Animal Health | 12.63 Bn | 12.20 Bn | 785.00 Mn | 1,902.00 |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | -96.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 480.00 |
| Dec 31, 2025 | 357.00 |
| Sep 30, 2025 | 287.00 |
| Jun 30, 2025 | 249.00 |
| Mar 31, 2025 | 226.00 |
| Dec 31, 2024 | 3,518.00 |
| Sep 30, 2024 | 4,164.00 |
| Jun 30, 2024 | 1,185.00 |
| Mar 31, 2024 | 1,268.00 |
| Dec 31, 2023 | 467.00 |
| Sep 30, 2023 | 343.00 |
| Jun 30, 2023 | 338.00 |
| Mar 31, 2023 | -25.00 |
| Dec 31, 2022 | 2,296.00 |
| Sep 30, 2022 | 2,165.00 |
| Jun 30, 2022 | 2,193.00 |
| Mar 31, 2022 | 2,306.00 |
| Dec 31, 2021 | -1,416.00 |
| Sep 30, 2021 | -1,774.00 |
| Jun 30, 2021 | -2,546.00 |